Search

everythinglearnresearchcommunity

for

Search:↓

Males had more severe COVID-19 symptoms, but their risk of death was only slightly higher than females.

Hair regrows faster in alopecia areata than skin re-pigments in vitiligo due to differences in stem cells and treatment effects.

Four specific genes are linked to keloid formation and could be potential treatment targets.

Understanding skin reactions to radiation has improved, helping to reduce injuries and prevent skin cancer.

The combination of vitamin D analogues with potent steroids is a favorable treatment for alopecia areata with fewer side effects.

Folliculotropic Mycosis Fungoides requires stage-based treatment, with early stages using skin therapies and advanced stages needing aggressive treatments.

Antigen presenting cells around hair follicles are crucial in SLE-related hair loss.

Targeting immune pathways like JAK/STAT may help treat frontal fibrosing alopecia.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

IL-4 and IL-13 might play a role in a type of hair loss similar to alopecia areata.

Both Th1 and Th2 immune responses are increased in alopecia areata, with Th2 response more strongly linked to how severe the disease is.

Aging reduces skin cell renewal and defense against germs due to TGFbeta, but blocking TGFbeta could help restore these functions.

Small molecule DMF improves psoriasis and multiple sclerosis, adult skin cells can be made to grow new hair, certain skin cells initiate hair growth, IL-17C controls gut health and can cause skin inflammation, and skin cells produce IL-17 that can lead to psoriasis.

Dupilumab can help regrow hair in alopecia areata but stopping it may cause hair loss again.

Frontal fibrosing alopecia shows increased inflammation and JAK-STAT pathway activity without reduced hair proteins.

Fzd2 is important for skin and hair development through various signaling ways.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

Alopecia areata is caused by an immune response, and targeting immune cells might help treat it.

Lower CD200R1 on certain immune cells is linked to more severe rheumatoid arthritis and immune imbalance.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Ebastine may promote hair regrowth by increasing cell growth through the ERK pathway.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.

A protein called lfTSLP is important in causing allergic and other skin diseases and could be a target for treatment.

Chronic graft-versus-host disease in the skin shows strong Th1 immune response and unique barrier issues.

Hair dye ingredient PPD can cause severe allergic reactions, including facial swelling.

Pimecrolimus cream is not effective for treating alopecia areata.

The Hairless gene is crucial for healthy skin and hair growth.

Apremilast did not work for treating severe alopecia areata.

A woman with alopecia regrew her hair after taking a higher dose of tocilizumab.

People with certain skin diseases have higher levels of the hormone prolactin in their blood.